Integrated analyses reveal IDO1 as a prognostic biomarker coexpressed with PD-1 on tumor-associated macrophages in esophageal squamous cell carcinoma.

Front Pharmacol · 2024 · PMC11439782 · PMID 39351094

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantP < 0.001actually significant

Coexpression analysis revealed a highly significant overlap of IDO1 and PDCD1 in DCs ( P < 0.001; Figure 4D ) and macrophages ( P < 0.05; Figure 4D ), but not in monocytes, mast cells, and neutrophils (all P > 0.05; Figure 4D ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.